Form 4: Cartesian Therapeutics Chief Medical Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Milos Miljkovic, Chief Medical Officer of Cartesian Therapeutics, sold shares to cover tax obligations related to vesting restricted stock units.
Summary
- Milos Miljkovic, the Chief Medical Officer of Cartesian Therapeutics, sold a total of 1,880 shares of common stock.
- The sales occurred on January 3, 2025, and January 6, 2025.
- On January 3, 2025, 932 shares were sold at a price of $16.7219 per share.
- On January 6, 2025, 948 shares were sold at a price of $16.8322 per share.
- These sales were made to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
- Following these transactions, Miljkovic beneficially owns 35,393 shares of Cartesian Therapeutics common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction for an executive, not indicative of any significant positive or negative sentiment. The sale is for tax purposes, which is a normal occurrence.
Industry Context
This is a routine transaction for company executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.
Comparison to Industry Standards
- Sales of shares by executives to cover tax obligations are a common practice across the biotechnology industry.
- Many companies use restricted stock units as part of their compensation packages, leading to similar transactions when these units vest.
- The volume of shares sold by Miljkovic is relatively small compared to the total outstanding shares of the company, and is not unusual for a company of this size.
Stakeholder Impact
- The sale of shares by the Chief Medical Officer may have a minor impact on the stock price, but is unlikely to be significant given the relatively small volume of shares sold.
Key Dates
| Date | Description |
|---|---|
| 01/03/2025 | Milos Miljkovic sold 932 shares of common stock at $16.7219 per share. |
| 01/06/2025 | Milos Miljkovic sold 948 shares of common stock at $16.8322 per share. |
| 01/07/2025 | Date of signature for the SEC Form 4 filing. |
Keywords
Cartesian Therapeutics, Milos Miljkovic, stock sale, insider trading, restricted stock units, tax obligations, RNAC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.